Skip to main content

Table 8 Analysis of over 50% percentage change of NLR in patients of response and non-response groups

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group Trend
Decrease > 50% Increase > 50% No change Total
Response 16 32 40 88
Non-response 2 10 19 31
Total 18 42 59 119
P value 0.187